burn wounds
| 8 min read
A new product takes on the tricky process of tissue regeneration.
| 3 min read
Phase 1/2 trial will assess safety and efficacy of RECCE 327 against broad range of infectious diseases on chronic burn wounds
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe